A novel automatic injection device developed to increase safety, speed, and ease of use in emergency medical situations.
Patents submitted in key jurisdictions
A medical device designed to improve hypodermic medication delivery systems with a safer and more robust needle. NeedSafe is the safest needle protective and delivery device to be ever developed.
Patent issued/pending in various jurisdictions
Prototype under development
David Kim, MD, FRCPC, MSc, DAvMedCEO
David is a recipient of the BC Community Achievement Award for his work in leadership, philanthropy, and process optimization. He joins Difinity with significant experience in leading and executing within the charitable sector as the founder and director of various non-profit organizations. David is a physician specializing in Emergency Medicine with subspecialty training in Aerospace Medicine and holds a MSc in Aerospace Medicine from King's College London.
Damien Tak, BSc, CPLCTO
Damien has a Bachelor of Science with Distinction from UBC and has most recently worked as a public servant for the Government of Canada. He has worked in leading and founding roles with a number charities and organizations and is always looking to solve problems. Damien wants to empower those around him and has a passion to change the world on a macro scale.
Larry Murphy, BSc, RAC-US, ISO Lead AuditorChief Regulatory Officer
Larry has an extensive work history in both pharmaceutical and medical device companies across the spectrum of Clinical Affairs, Regulatory Affairs, Quality Assurance and Quality Control. Larry has held senior leadership positions at several successful Canadian biotech companies. He has experience working with regulatory bodies including Health Canada, FDA and European authorities. Larry has a BSc Biochemistry from the University of Victoria. Larry has a certified ISO 13485 lead auditor and holds a Regulatory Affairs Certification (US).
Adrianna Rowe, MD, FRCPCPharmacotherapeutics
Adrianna is an emergency physician at University Health Network's Toronto Western and Toronto General hospitals. She has an interest in clinical pharmacology and toxicology, and is currently completing a fellowship in clinical pharmacology and toxicology at the University of Toronto. She aspires to apply her expertise to improve patient care through helping Difinity in improving drug administration and prevention of adverse drug events.
Trevor Skutezky, MD, FRCPC, MBA, BAScBusiness Development
Trevor is a physician specializing in Emergency Medicine at Vancouver General Hospital. He holds an undergraduate degree in engineering from Queen's University and a Master of Business Administration from Ivey Business School. He brings experience in project management, quality improvement, medical research and first hand healthcare knowledge to the Difinity team.
Ishan Aditya, MDStrategy
Ishan is a medical student at the University of Toronto who completed his undergraduate studies in the Bachelor of Health Sciences (Honours) Program at McMaster University. He is a well-published researcher, brings extensive leadership experience, and is an internationally accomplished public speaker. He wants to apply his passion for comprehensive patient care through Difinity to develop accessible technology to create preventative health solutions.
Roh Amromanoh, BME, MEngProduct Development & Market Entry
Roh holds a Biosystems Engineering undergraduate degree specializing in Biomedical Engineering, as well as a Master of Science in Mechanical Engineering from the University of Manitoba. He is currently a Master of Business Administration (MBA) student at the University of Manitoba and is passionate about start-ups and medical device innovation and management. He brings a combination of technical and business knowledge to the Difinity team.
Aidan McParland, MD, MScGrowth
Aidan is a resident physician specializing in Emergency Medicine at Vancouver General Hospital. He holds a master's degrees in Pain Biology at the University of New England and completed his medical degree at the University of Toronto. He brings experience in basic science, clinical trials, as well as academic and organizational leadership to the Difinity team
Since starting NeedSafe, we have submitted patents for IP protection and developed a working prototype.
We have submitted patents in various jurisdictions and have developed an alpha prototype with functionality for testing.
We have submitted grant proposals for research and development.
We are aiming to have a fully functioning device to undergo testing and manufacturing by the end of Q4 2022. We aim to submit and meet FDA, EU, and Health Canada Regulations for our device by the end of Q4 2023.
We are partnering with a global CDMO to further develop, test, and manufacture our device with the goal of undergoing verification & validation testing for FDA, EU, and Health Canada approval by Q4 2025.
We are aiming to have NeedSense being tested for data collection and processing in hospitals by the end of Q2 2022.
Let's Get In Touch
We look forward to hearing from you.